KIFC2 and neoplasm: It has been consistently shown that patients with MSI-H tumors exhibit a better prognosis.[24–26] In our study, we found that high expression of KIFC2 is an independent risk factor for worse prognosis in COAD, regardless of other factors such as MSI status, tumor location, and stage.